Jermod McCoy spent the 2024 season starting all 13 games for the Tennessee Volunteers, posting 44 tackles, four interceptions, and nine pass breakups while allowing exactly one touchdown across 640 coverage snaps. The Associated Press named him a Second-Team All-American and a First-Team All-SEC selection. Bleacher Report's NFL scouting department graded him as the No. 11 overall prospect on its final 2026 board. CBS Sports listed him at No. 6 and the top cornerback in the class. ESPN's last public mock had the Minnesota Vikings selecting him 18th overall on April 22. At his March 31 Tennessee Pro Day he ran the forty in 4.37 seconds, jumped 38 inches vertically, and broad-jumped ten feet, seven inches.
Then McCoy waited. Round 1 closed Thursday with seven cornerbacks gone and his name uncalled. Round 2 ended Friday the same way. Round 3 closed Friday night without a phone call. He fell to the No. 101 pick — the first selection of the fourth round — where the Las Vegas Raiders sent the No. 102 pick and a 2027 seventh-round selection to the Buffalo Bills to move up a single slot. General manager John Spytek then turned in the card on a player most every public board had ranked inside the top 20. McCoy was the first cornerback selected after Round 3 opened, and the second-largest faller of the entire weekend by consensus board.
The reason for the slide is not the torn anterior cruciate ligament McCoy suffered during individual offseason workouts in January 2025, the injury that cost him the entire 2025 college season. The reason is what was already inside the joint before the ACL tear. McCoy's right knee contains a bone plug — formally an osteochondral autograft, also known as an OATS procedure. Surgeons take a cylindrical piece of bone topped with a cap of articular cartilage from a non-load-bearing part of the joint and transplant it into a damaged area to fill a focal cartilage lesion. McCoy received the plug to address a degenerative cartilage issue that predates the ACL repair entirely.
Multiple team doctors flagged the same concern when grading the medical file: the plug will likely need to be replaced. A 2016 systematic review of osteochondral autograft outcomes followed 610 patients across 10 studies over a mean 10.2 years and reported successful long-term outcomes in 72 percent — meaning roughly one in four required revision or experienced symptomatic decline. Defect size, prior surgery, and age all correlate positively with failure. Yahoo Sports' Charles Robinson reported team medical staffs believe a second McCoy procedure would cost him at least one full season and could, in his source's words, effectively end his career. ESPN's Jeremy Fowler polled eight clubs and reported five had taken McCoy off their draft boards entirely.
The Raiders' decision to trade up reads differently in light of the medical poll. Spytek did not move because he had a unique read on the tape — every team graded that tape, and the consensus public ranking was inside the first 20 picks. Spytek moved because the medical-grade board his staff was working from converged with a piece of cap math. A first-round cornerback who returns to All-SEC form is the highest-leverage pick a Day 3 investment can produce. A first-round cornerback who needs a second OATS procedure inside two years still costs only the slotted Round 4 deal — a sub-$6 million depth flier that absorbs one roster spot and frees the cap by August of 2027.
The slot-value math is the loudest single fact of McCoy's weekend. Per Spotrac's 2026 rookie scale, the No. 18 pick is worth $20.4 million across four years with a fully guaranteed first-round contract and a fifth-year team option attached. The No. 101 pick is worth $5.5 million across four years with no fifth-year option and only the signing bonus guaranteed. The bone plug, in pure contract dollars, cost McCoy $14.95 million in expected guarantees. A Knoxville outlet rounded the lifetime figure closer to $20 million when factoring in the lost first-round endorsement market — McCoy's NIL agency had been booking deals priced against a Round 1 outcome since the day his Pro Day forty was clocked.
Frank Gore tore both anterior cruciate ligaments at the University of Miami before the 2005 NFL Draft and slid to the No. 65 pick, where the San Francisco 49ers took him; he played 16 seasons and finished as the third-leading rusher in NFL history. The medical comp is imperfect — Gore had no degenerative cartilage component, and the running back positional curve is generationally different from corner — but the structural lesson holds. Teams that buy at a discount on a known medical risk only need the player to clear one hurdle: the first contract. Spytek bought a top-15 evaluation at a top-100 price. The Raiders' downside is a roster spot. McCoy's downside is the second surgery.